Keywords: epo, revokes, biogens, rifn, beta, patent, european

EPO Revokes Biogens rIFN beta Patent

Article | 10 April 1997

Print This

- The European Patent Office has revoked Biogen's patent covering theproduction of recombinant beta interferon, as a result of the appeal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in